HLA is pleased to announce the complete dismissal of all criminal charges filed by the Attorney General of Massachusetts against a pharmacy and its owner. After a grand jury indicted the case, the Attorney General subsequently filed "nolle prosequi" notices announcing that it was abandoning the prosecution.

PBM Audits May Lead to Law Enforcement Referrals
As we have written about extensively, PBM audits can have severe consequences, including network termination and even criminal prosecution. In this case, following a PBM audit that noted inventory discrepancies, the PBM referred the case to law enforcement on the basis of suspected fraud.
The Attorney General's Office subsequently served grand jury subpoenas on the pharmacy and engaged in other evidence-gathering techniques typical of law enforcement. For example, detectives interviewed at least one referral source, a nearby physician, and numerous patients.
Medicaid Fraud Control Units (MFCUs)
As a condition to receiving federal funding for Medicaid programs, states are obligated to establish Medicaid Fraud Control Units, or MFCUs, to investigate and prosecute potential fraud. MFCUs are typically located in each state's Office of the Attorney General, the top law enforcement officer in each state.
MFCU investigators typically have many years of prior law enforcement experience and a background in computer forensics, financial crime, or data mining, including the use of artificial intelligence.
Attorney General Indictment
Following a grand jury investigation, the pharmacy and owner were indicted on seven criminal charges each, including Medicaid False Claims, Medicaid Reverse False Claims, False Health Care Claims to Private Insurer, Reverse False Health Care Claims to Private Insurer, Excess Charges to MassHealth Members, and two counts of Larceny.
For example, the government claimed that the owner had billed Medicaid and and other insurance plans almost $500,000 for 37,000 units of Zegerid, a heartburn medicine, even though the pharmacy's records indicated that the pharmacy had only purchased 12,000 units, a discrepancy of 25,000 units. In addition, the indictments alleged that the pharmacy had charged MassHealth patients cash for "early refills" of controlled substances in violation of Medicaid laws.
HLA's Defense Strategy
Because HLA's attorneys previously served as federal and state prosecutors, we know how difficult it can be to prove guilt "beyond a reasonable doubt." Accordingly, we often use that insight to persuade the government to abandon an "all or nothing" strategy and strike a negotiated resolution.
In this case, however, we demanded an immediate jury trial based on our analysis of the case. While the size of the inventory discrepancy was large, our attorneys believed that the client had not acted with criminal intent.
Attorney General Dismisses All Charges
Ultimately, the Attorney General's Office agreed with HLA. Rather than face a public loss in court, the Attorney General dismissed the case before trial. In addition, the client achieved a negotiated resolution in which he admitted no wrongdoing, was permitted to remain in network with MassHealth and other plans, and experienced no licensing consequences, exclusion, or professional discipline.
HLA is Available to Help
If you are facing an aggressive PBM audit with inventory or other discrepancies, call or email before the audit gets referred to law enforcement. If you are the subject of an investigation by law enforcement, we can help stop charges being brought. And if you are the subject of filed criminal charges, we can help resolve the matter before trial or defend your innocence in court.
Frequently Asked Questions
What are the recent victories Health Law Alliance has achieved against OptumRx?
Health Law Alliance has recently achieved notable victories against OptumRx by successfully obtaining reconsideration of the PBM's termination decisions for numerous pharmacies. These legal successes have allowed pharmacies to continue serving their communities without disruption, highlighting the firm's expertise in healthcare law and its dedication to protecting its clients' interests.
How does Health Law Alliance protect pharmacies from unjust PBM terminations?
Health Law Alliance protects pharmacies from unjust PBM terminations by employing a strategic legal approach that includes robust advocacy, comprehensive documentation, and detailed information to refute erroneous audit findings. Their healthcare defense attorneys work closely with PBMs to address concerns about fraud, waste, and abuse, ensuring that pharmacies can continue their operations and avoid unnecessary government investigations.
Why should pharmacies choose Health Law Alliance to fight PBM terminations?
Pharmacies should choose Health Law Alliance to fight PBM terminations because of the firm's proven track record of successfully challenging unreasonable PBM decisions. With a deep understanding of healthcare law and extensive experience in navigating complex legal landscapes, Health Law Alliance provides powerful advocacy and meticulous legal strategies to protect pharmacies' rights and ensure their ability to serve their communities.
Please contact us at (800) 425-4125 if you have any questions or are seeking representation for a PBM matter.
Understanding Subpoenas for Medical Records: Types, Issuers, and Legal Risks
Many healthcare providers face the challenge of dealing with subpoenas for medical records. These legal demands require careful handling. It's important to balance the duty to comply with court processes and privacy laws.
Read More >>How to Respond to an OIG Subpoena: Defense Strategies for Healthcare Providers
Receiving an OIG subpoena means your healthcare practice is under federal investigation, typically for healthcare fraud or regulatory violations. Understanding how to respond to an OIG subpoena effectively is crucial to protecting your practice.
Read More >>Provider Alert: New York Physician Indicted in Louisiana for Virtually Prescribing Abortion Medication
New York doctor indicted in Louisiana for prescribing abortion pills via telehealth, raising legal battles over state laws, shield protections, and provider risks post-Dobbs.
Read More >>DEA Announces Three New Rules Expanding Telehealth Access
This article outlines the details of the three new telehealth rules promulgated by the Drug Enforcement Agency (DEA) and their impact on telehealth providers.
Read More >>